Friday, November 10, 2017
CORE Diagnostics Hosts a Confluence of Innovators and Entrepreneurs at ICC 2017 in Bengaluru
Liquid biopsy, genetic testing offer new potent weapons for diagnosis and treatment
CORE conducts unique Startup Pitch Fest to select and reward innovative and potentially path-breaking entrepreneurial ideas in the healthcare domain
India’s most trusted diagnostics partner CORE Diagnostics Pvt. Ltd is supporting a comprehensive discussion platform for Oncologists and medical experts to talk in depth about the Indian perspectives on genetic mutation and its role in augmenting cancer risk at the 2nd chapter of the Indian Cancer Congress. Over 3500 oncologists have converged at the conference to talk about latest strategies in treatment and prevention against cancer.
The event is being held from Nov 8-12 here at the Silicon Valley of India and has experts in medical oncology deliberating upon the Indian as well as global perspectives in the incidence of different types of cancers and the causes of their rising prevalence. A rapidly expanding start up and an expert in Oncology testing, CORE have constantly differentiated themselves by their innovative edge in the diagnostics market.
Keeping up with the newest technologies in the cancer detection and prevention space, CORE has an entire section dedicated to the latest buzz in the segment called COREtalks at their booth. Some of the featured talks include “BRCA: An Indian perspective on incidence and patterns,” " Liquid Biopsy: An answer to when tissue is an issue," and Next Generation Sequencing and beyond in the management of Cancers - Where do we stand?” CORE is also hosting a Lunch Symposium on Machine Learning & Artificial Intelligence in Oncology - The Myth & the Reality as well as participating on several debates and panel discussions.
CORE Diagnostics has also initiated a one of its kind effort to boost innovation as a means to usher in potentially game changing ideas in the field of Indian healthcare/
Underlining the need for promoting innovation in healthcare, CORE Diagnostics’ Founder & Managing Director, Zoya Brar said, “Putting appropriate thrust on innovation can bring about revolutionary solutions in healthcare. This is particularly important for a country like India where dynamic ideas are needed to expand the reach of quality healthcare to rural as well as remote areas. In this direction, for the first time ever at a conference, with a platform as great as the ICC, we’re hosting a unique ‘Startup Pitch Fest’. This fest will provide a one of its kind platform to boost brilliant ideas in the healthcare domain that can play a pivotal role in diagnosis and positively impact patient treatment. The winner gets cash prizes worth Rs 3 lakhs. I’m very excited and look forward to hearing from the selected finalists for COREcatalyst on November 10.”